Latest News

Sinovac Amends Shareholder Rights Plan

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration date of the plan from February 22, 2020 to February 22, 2021. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vacci

Source link

Related posts

The Science Behind Feeling Rested And Why It's Important


Extensive brain inflammation present in fibromyalgia patients, shows recent multicenter study


Fluoridated water protects baby teeth, too


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy